AGIO

Agios Pharmaceuticals (AGIO)

About Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Details

Daily high

$36.30

Daily low

$35.13

Price at open

$35.50

52 Week High

$62.58

52 Week Low

$20.96

Market cap

2.0B

Dividend yield

0.00%

Volume

3.2M

Avg. volume

1.2M

P/E ratio

3.12

Agios Pharmaceuticals News